Profiles Sponsors
Allergan Aesthetics, a division of AbbVie
At Allergan Aesthetics, a division of AbbVie, we develop, manufacture, and market a portfolio of leading aesthetics brands and products around the world. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. We create the products and technologies that drive the advancement of aesthetic medicine. With our own research and development team focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available. At Allergan Aesthetics™ we believe in the remarkable impact confidence can have on the lives, businesses, and careers of those we serve through our history of a company built on patient-care, education and support of our customers, and our commitment to putting the patients we serve first. That’s why we dedicate ourselves, every day, united by a single purpose: empowering confidence. For our customers, their patients and one another.
American Express
American Express is a globally integrated payments company issuing cards to consumers and businesses and providing card acceptance in shops, e-commerce and B2B. For the management of business spend, American Express provides Corporate Credit Cards, Business Cards and virtual payment solutions to companies of different sizes.
Learn more at americanexpress.de, linkedin.com/company/american-express, facebook.com/americanexpress und instagram.com/americanexpress and connect with us.
Croma-Pharma GmbH
Croma Pharma GmbH is a family business based in Austria. It was founded in 1976 and is specialized in the industrial production of hyaluronic acid syringes. With over 500 employees, some of them also based in Germany, France, the Netherlands, Poland, Portugal, Rumania, Spain, Switzerland, Great Britain, Italy, Brazil and its home country Austria, the products are distributed in more than seventy countries. Within this worldwide distribution network, Croma Pharma GmbH has a focus on its own branded products in the segment of minimal invasive aesthetic medicine. Among the wide range of saypha® injectables, from the own production facility in Leobendorf (Austria) and the Princess® PDO Threads, Croma also has an innovative PRP System, called Arthrex ACP® which is a revolution in autohemotherapy. The newest addition to the portfolio is juvenus, which is an innovative injectable, based on polymerized polynucleotides (natural origin), to stimulate fibroblasts, hydrate the skin and it also has an antioxidant effect.
Amongst others Croma Pharma also has a wide range in skincare products, for example sheet masks for different application areas and the farewellTM sera collection, based on hyaluronic acid.
Galderma
Galderma is the world’s largest independent dermatology company, present in approximately 100 countries. Since our inception in 1981, we have been driven by a complete dedication to dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine. Focused on the needs of consumers and patients, we work in partnership with healthcare professionals to ensure superior outcomes. Because we understand that the skin we’re in shapes our life stories, we are advancing dermatology for every skin story. For more information: www.galderma.com
Motiva
Establishment Labs® Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 80 countries through exclusive distributors or the Company’s direct salesforce.
In March 2018, Establishment Labs® received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implants® clinical trial in the United States. After more than a decade on the market, from 2010 to 2022, and already 2 million implants sold, Motiva Implants® have consistently reported rates of less than 1 % device-related complications leading to reoperation.
POLYTECH Health & Aesthetics
POLYTECH Health & Aesthetics is proud to be Sponsor for VDÄPC & GBÄM. We are the only German manufacturer of silicone breast implants. 2021 marked our 35th anniversary serving the needs of surgeons and patients in over 80 countries around the world.
At POLYTECH we know that our success can only come from your success. We work incredibly hard every day to repay the trust that you and your patients invest in our products.
Our passion to help you enhance your patients’ lives, drives our focus on delivering the widest and most innovative range of breast implants on the market today.
Every surgeon is unique. Every patient is unique. “One key does not fit every lock”.
We hope that you have a wonderful meeting.
POLYTECH – QUALITY YOU CAN FEEL
Anzeige
In Cooperation with
